chrysamine g has been researched along with florbetapir f 18 in 2 studies
| Studies (chrysamine g) | Trials (chrysamine g) | Recent Studies (post-2010) (chrysamine g) | Studies (florbetapir f 18) | Trials (florbetapir f 18) | Recent Studies (post-2010) (florbetapir f 18) |
|---|---|---|---|---|---|
| 16 | 0 | 3 | 365 | 24 | 342 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SR; Kung, HF; Qu, W; Skovronsky, D; Zhang, W | 1 |
| Choe, YS; Lee, I; Lee, JH; Yang, J | 1 |
2 other study(ies) available for chrysamine g and florbetapir f 18
| Article | Year |
|---|---|
18F stilbenes and styrylpyridines for PET imaging of A beta plaques in Alzheimer's disease: a miniperspective.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Brain; Fluorine Radioisotopes; Humans; Plaque, Amyloid; Positron-Emission Tomography; Pyridines; Stilbenes; Styrenes; Tissue Distribution | 2010 |
Synthesis and evaluation of 1-(4-[¹⁸F]fluoroethyl)-7-(4'-methyl)curcumin with improved brain permeability for β-amyloid plaque imaging.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Blood-Brain Barrier; Brain; Curcumin; Drug Evaluation, Preclinical; Fluorine Radioisotopes; Humans; Mice; Mice, Transgenic; Peptide Fragments; Permeability; Plaque, Amyloid; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Tissue Distribution | 2011 |